Sleep–inducing effects of carbamazepine (tegretol) and clorazepate (tranxene) in the primary persistent insomnia
thumbnail.default.placeholder
Дата
2008-06
Автори
Maximov, G.
Maximov, K.
Заглавие на списанието
ISSN на списанието
Заглавие на тома
Издател
Централна медицинска библиотека, МУ София / Central Medical Library - MU Sofia
Резюме
Primary persistent insomnia (PPI) occurs independently of any known
physical or mental condition and is among the most difficult problems in sleep disorders. For
the treatment of PPI, comedication of clorazepate (Tranxene) in dosage 1 capsule of 10 mg
and carbamazepine (Tegretol) in dosage 1 tablet of 200 mg in 32 out-patients for 30 days
was applied. Normalization of sleep was achieved in 29 patients (90,63%). Side effects were
few (5 patients) and of little importance, and the treatment was well tolerated.
Описание
Address for correspondence:
Gueorgui Konstantinov Maximov
Military Medical Academy
Medical Center for Neurology and Neurosurgery
3, G. Sofiyski str.
1601 Sofia
Bulgaria
e_mail: neuromaxi@yahoo.com
Ключови думи
primary persistent insomnia, clorazepate (Tranxene), carbamazepine (Tegretol)
Цитирания
Maximov, G., and K. Maximov. Sleep–inducing effects of carbamazepine (tegretol) and clorazepate (tranxene) in the primary persistent insomnia - Acta Medica Bulgarica, 35, 2008, № 1, 19-24.